SEC Form 4 · accession 0001209191-17-005612
DUCOMMUN INC /DE/ · DCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen G Oswald
Officer — President & CEO · Director
Period of report
Jan 23, 2017
Accepted (ET)
Jan 25, 2017 · 7:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000030305
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2017 | A | 21,000 | $0.00 | A | 21,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option - Right to BuyF1,F2 | $29.53 | Jan 23, 2017 | A | 28,000 | A | Jan 23, 2018 | Jan 22, 2024 | Common Stock | 28,000 | 28,000 | D |
| Performance RightsF3 | — | Jan 23, 2017 | A | 80,000 | A | — | Jan 22, 2024 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1The option represents the right to purchase common stock granted under the Ducommun Incorporated Employee Stock Option Plans, which are Rule 16b-3plans.
- F2The option will vest in four equal installments on January 23, 2018, 2019, 2020 and 2021.
- F3Each performance right represents a contingent right to receive one share of Ducommun common stock. One-third of the performance rights vest when the average of the closing price of Ducommun's common stock on the New York Stock Exchange over a period of 30 consecutive trading days exceeds $42.21, $56.28 and $70.35, respectively.